| [1] |
Patil S, Mccauley JC, Pulido P, et al. How do knee implants perform past the second decade? Nineteen- to 25-year followup of the press-fit condylar design TKA[J]. Clin Orthop Relat Res, 2015, 473(1): 135-140.
|
| [2] |
Deirmengian C, Kardos K, Kilmartin P, et al. Diagnosing periprosthetic joint infection: has the era of the biomarker arrived？[J]. Clin Orthop Relat Res, 2014, 472(11): 3254-3262.
|
| [3] |
Springer BD. The diagnosis of periprosthetic joint infection [J]. J Arthroplasty, 2015, 30(6): 908-911.
|
| [4] |
Parvizi J, Shohat N, Gehrke T. Prevention of periprosthetic joint infection new guidelines [J]. Bone Joint J, 2017, 99B(4, B):3-10.
|
| [5] |
Whitehouse MR, Parry MC, Konan S, et al. Deep infection after hip arthroplasty staying current with change [J]. Bone Joint J, 2016, 98B(1, A): 27-30.
|
| [6] |
George DA, Gant V, Haddad FS. The management of periprosthetic infections in the future. A review of new forms of treatment[J]. Bone Joint J, 2015, 97B(9): 1162-1169.
|
| [7] |
Choi HR, Agrawal K, Bedair H. The diagnostic thresholds for synovial fluid analysis in late periprosthetic infection of the hip depend on the duration of symptoms [J]. Bone Joint J, 2016, 98B(10): 1355-1359.
|
| [8] |
Parvizi J, Zmistowski B, Berbari EF, et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society[J]. Clin Orthop Relat Res, 2011, 469(11): 2992-2994.
|
| [9] |
Della Valle C, Parvizi J, Bauer TW, et al. Diagnosis of periprosthetic joint infections of the hip and knee[J]. J Am Acad Orthop Surg, 2010, 18(12): 760-770.
|
| [10] |
Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria[J]. J Arthroplasty, 2018, 33(5): 1309-1314.
|
| [11] |
Mesquida M, Molins B, Llorenc V, et al. Targeting interleukin-6 in autoimmune uveitis[J]. Autoimmun Rev, 2017, 16(10): 1079-1089.
|
| [12] |
Song M1. Kellum JA. Interleukin-6[J]. Crit Care Med, 2005, 33(12 Suppl): S463-S465.
|
| [13] |
Selberg O, Hecker H, Martin M, et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6[J]. Crit Care Med, 2000, 28(8): 2793-2798.
|
| [14] |
Xie K, Dai K, Qu XH, et al. Serum and synovial fluid interleukin-6 for the diagnosis of periprosthetic joint infection[J/OL]. Sci Rep, 2017, 7(1): 1496. doi: 10.1038/s41598-017-01713-4. |
| [15] |
Wirtz DC, Heller KD, Miltner O, et al. Interleukin-6: a potential inflammatory marker after total joint replacement[J]. Int Orthop, 2000, 24(4): 194-196.
|
| [16] |
Randau TM, Friedrich MJ, Wimmer MD, et al. Interleukin-6 in serum and in synovial fluid enhances the differentiation between periprosthetic joint infection and aseptic loosening [J/OL]. PLoS One, 2014, 9(2): e89045. doi: 10.1371/journal.pone.0089045. |
| [17] |
Tande AJ, Patel R. Prosthetic joint infection[J]. Clin Microbiol Rev, 2014, 27(2): 302-345.
|
| [18] |
El-Khier EN, Ael-R GE, Elgeidy A, et al. Assessment of interleukin-6 and other inflammatory markers in the diagnosis of Egyptian patients with periprosthetic joint infection [J]. Egypt J Immunol, 2013, 20(2): 93-99.
|
| [19] |
Elgeidi A, Elganainy AE, Abou Elkhier N, et al. Interleukin-6 and other inflammatory markers in diagnosis of periprosthetic joint infection[J]. Int Orthop, 2014, 38(12): 2591-2595.
|
| [20] |
Lenski M, Scherer MA. Synovial IL-6 as inflammatory marker in periprosthetic joint infections[J]. J Arthroplasty, 2014, 29(6): 1105-1109.
|
| [21] |
Ettinger M, Calliess T, Kielstein JT, et al. Circulating biomarkers for discrimination between aseptic joint failure, low-grade infection, and high-grade septic failure[J]. Clin Infect Dis, 2015, 61(3): 332-341.
|
| [22] |
Bouaicha S, Blatter S, Moor BK, et al. Early serum procalcitonin level after primary total hip replacement[J/OL]. Mediators Inflamm, 2013, (2013): 927636. doi: 10.1155/2013/927636. |
| [23] |
闫立伟，王文波，李昭旭，等．血清降钙素原在诊断膝关节置换术后早期感染的意义[J]．中国骨与关节杂志，2015，4(4):317-319.
|
| [24] |
Gendrel D, Bohuon C. Procalcitonin, a marker of bacterial infection[J]. Infection, 1997, 25(3):133-134.
|
| [25] |
Lin KH, Wang FL, Wu MS, et al. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis[J]. Diagn Microbiol Infect Dis, 2014, 80(1): 72-78.
|
| [26] |
Shen CJ, Wu MS, Lin KH, et al. The use of procalcitonin in the diagnosis of bone and joint infection: a systemic review and meta-analysis [J]. Eur J Clin Microbiol Infect Dis, 2013, 32(6): 807-814.
|
| [27] |
危立军，罗军，易观俊，等．血清降钙素原及血沉与C-反应蛋白联合检测诊断化脓性关节炎临床价值[J]．中华医院感染学杂志，2015，25(20):4664-4666.
|
| [28] |
Xie K, Qu XH, Yan MN. Procalcitonin and alpha-defensin for diagnosis of periprosthetic joint infections [J]. J Arthroplasty, 2017, 32(4): 1387-1394.
|
| [29] |
Yuan K, Li WD, Qiang Y, et al. Comparison of procalcitonin and C-reactive protein for the diagnosis of periprosthetic joint infection before revision total hip arthroplasty[J]. Surg Infect (Larchmt), 2015, 16(2): 146-150.
|
| [30] |
Glehr M, Friesenbichler J, Hofmann GA, et al. Novel biomarkers to detect infection in revision hip and knee arthroplasties[J]. Clin Orthop Relat Res, 2013, 471(8): 2621-2628.
|
| [31] |
李睿，李想，倪明，等．对降钙素原诊断关节假体周围感染的评价[J]．解放军医学院学报，2016，37(4):339-342.
|
| [32] |
Drago L, Vassena C, Dozio E, et al. Procalcitonin, C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1 as markers of postoperative orthopaedic joint prosthesis infections S[J]. Int J Immunopathol Pharmacol, 2011, 24(2): 433-440.
|
| [33] |
Lin CT, Lu JJ, Chen YC, et al. Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department[J/OL]. Peer J, 2017, 5: e4094. doi: 10.7717/peerj.4094. |
| [34] |
Saleh A, George J, Faour M, et al. Serum biomarkers in periprosthetic joint infections[J]. Bone Joint Res, 2018, 7(1): 85-93.
|
| [35] |
Deirmengian C, Kardos K, Kilmartin P, et al. The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip[J]. Clin Orthop Relat Res, 2015, 473(1): 198-203.
|
| [36] |
Deirmengian C, Kardos K, Kilmartin P, et al. The alpha-defensin test for periprosthetic joint infection responds to a wide spectrum of organisms[J]. Clin Orthop Relat Res, 2015, 473(7): 2229-2235.
|
| [37] |
Bingham J, Clarke H, Spangehl M, et al. The alpha defensin-1 biomarker assay can be used to evaluate the potentially infected total joint arthroplasty [J]. Clin Orthop Relat Res, 2014, 472(12): 4006-4009.
|
| [38] |
Frangiamore SJ, Gajewski ND, Saleh A, et al. α-Defensin accuracy to diagnose periprosthetic joint infection-best available test？[J]. J Arthroplasty, 2016, 31(2): 456-460.
|
| [39] |
Deirmengian C, Kardos K, Kilmartin P, et al. Combined measurement of synovial fluid α-defensin and C-reactive protein levels: highly accurate for diagnosing periprosthetic joint infection [J]. J Bone Joint Surg Am, 2014, 96(17): 1439-1445.
|
| [40] |
Alvand A, Rezapoor M, Parvizi J. The role of biomarkers for the diagnosis of implant-related infections in orthopaedics and trauma [J]. Adv Exp Med Biol, 2017, 971:69-79.
|
| [41] |
Hansrani V, Khanbhai M, McCollum C. The diagnosis and management of early deep vein thrombosis [J]. Adv Exp Med Biol, 2017, 906:23-31.
|
| [42] |
Schwameis M, Steiner MM, Schoergenhofer C, et al. D-dimer and histamine in early stage bacteremia: a prospective controlled cohort study[J]. Eur J Intern Med, 2015, 26(10): 782-786.
|
| [43] |
Gando S. Role of fibrinolysis in sepsis [J]. Semin Thromb Hemost, 2013, 39(4): 392-399.
|
| [44] |
Bytniewski P, Machala W, Romanowski L, et al. The dynamics of D-dimerlevel fluctuation in patients after the cemented and cementless total hipand total knee replacement [J/OL]. J Orthop Surg Res, 2014, 9:89. doi: 10.1186/s13018-014-0089-0. |
| [45] |
Ribera T, Monreal L, Armengou L, et al. Synovial fluid D-dimerconcentration in foals with septic joint disease[J]. J Vet Intern Med, 2011, 25(5): 1113-1117.
|
| [46] |
Lee YS, Lee YK, Han SB, et al. Natural progress of D-dimer following total joint arthroplasty: a baseline for the diagnosis of the early postoperative infection [J/OL]. J Orthop Surg Res, 2018, 13(1): 36. doi: 10.1186/s13018-018-0730-4. |
| [47] |
Lee YS, KooK-H, Kim HJ, Tian S, et al.Synovial fluid biomarkers for the diagnosis of periprosthetic joint infection: a systematic review and meta-analysis[J]. J Bone Joint Surg Am, 2017, 99:2077-2084.
|
| [48] |
Shahi A, Kheir MM, Tarabichi MA, et al. Serum D-dimer test is promising for the diagnosis of periprosthetic joint infection and timing of reimplantation[J]. J Bone Joint Surg Am, 2017, 99(17): 1419-1427.
|
| [49] |
Busso N, Hamilton JA. Extravascular coagulation and the plasminogen activator/plasmin system in rheumatoid arthritis[J]. Arthritis Rheum, 2002, 46(9): 2268-2279.
|